Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Imaging Diagnostic Systems Highlights New Clinical Results at RSNA 2005

   Imaging Diagnostic Systems logo. (PRNewsFoto)

FORT LAUDERDALE, FL USA
    FORT LAUDERDALE, Fla., Nov. 8 /PRNewswire-FirstCall/ -- Imaging Diagnostic
Systems, Inc., (OTC Bulletin Board: IMDS) announced that IDSI will display new
clinical results and feature the CT Laser Mammography System at RSNA 2005,
November 27 - December 2, in Chicago, Illinois.  IDSI will be located at Booth
#5139 in the South Hall.
    (Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO )
    "We have made impressive clinical progress since last year's RSNA," stated
Tim Hansen, IDSI Chief Executive Officer.  "Earlier this year, our first peer-
reviewed CT Laser Mammography paper was published.  Our exam volume has risen
to over 6,000 as a result of the efforts of our international users and our
research partners.  Many of these new clinical cases will be presented at this
important global imaging venue.  Our results underscore our extensive
experience and leadership in laser optical breast imaging.  We are looking
forward to sharing these developments with breast and molecular imaging
specialists."
    RSNA 2005 is the 91st Scientific Assembly and Annual Meeting of the
Radiological Society of North America.  A forum for radiologic science and
technology, RSNA features scientific papers, posters, courses, lectures,
symposia, and exhibits.  In 2004, the annual meeting attracted over 60,000
attendees.

    The CT Laser Mammography (CTLM(R)) system is the first patented breast
imaging system that utilizes state-of-the-art laser technology and patented
algorithms to create 3-D cross-sectional images of the breast. It is a non-
invasive, painless examination that does not expose the patient to radiation
or require breast compression.  Imaging Diagnostic Systems has received CE
Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing,
ISO 9001:2000-13488 certification and FDA export certification for its CT
Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA)
from the Food and Drug Administration (FDA) for its CTLM(R) system to be used
as an adjunct to mammography.
    Please visit Imaging Diagnostic Systems' website at: http://www.imds.com
for additional information.

    In conjunction with the provisions of the Safe Harbor section of the
Private Securities Litigation Reform Act of 1995, this news release may
contain forward-looking statements pertaining to future anticipated projected
plans, performances and developments, as well as other statements relating to
future operations. All such forward-looking statements are necessarily only
estimates of future results and there can be no assurance that actual results
will not materially differ from expectation. Further information on potential
factors that could affect Imaging Diagnostic Systems, Inc., is included in the
Company's filing with the Securities Exchange Commission.

     Investor Relations:
     Rick Lutz
     404-261-1196
     lcgroup@mindspring.com


SOURCE Imaging Diagnostic Systems, Inc.




Back to Topback to top

Related links:
  • http://www.imds.com
    Photo Notes:
    NewsCom: 
    http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO
    AP Archive: http://photoarchive.ap.org
    PRN Photo Desk, photodesk@prnewswire.com
    CONTACT:
    Investor Relations, Rick Lutz,
    +1-404-261-1196, or lcgroup@mindspring.com, for Imaging
    Diagnostic Systems, Inc.